Q1:18 Health Care Spending: $112.9 Billion

Q1:18 Health Care Spending: $112.9 Billion

by | Apr 27, 2018 1:02 pm | Healthcare Market Updates

A total of $112.9 billion was spent to fund the 386 transactions reported in Q1:18, based on disclosed prices. Total spending was about 2% lower than the $115.1 billion reported in the previous quarter. The Other Services sector dominated the dollar side of deal making, accounting for 60% ($68.2 billion) of spending. A single deal accounted for 59% of the quarter’s total, as Cigna (NYSE: CI) announced its acquisition of Express Scripts Holdings (NYSE: ESRX) for $67 billion, including debt. Source: HealthCareMandA.com, April 2018 The Biotechnology sector made up 28% ($31.2 billion) of spending in the first quarter. Many of the deals were front-loaded into January, so their announcements... Read More »
Health Care M&A Weekly Deals, The Week Ending April 20, 2018

Health Care M&A Weekly Deals, The Week Ending April 20, 2018

by | Apr 20, 2018 3:49 pm | Healthcare Market Updates

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care     Acquirer Target Price Center for Discovery Cliffside Malibu Merger       Biotechnology     Acquirer Target Price Basilea Pharmaceutica International Limited Exclusive license to... Read More »
Q1:18 Health Care Spending: $112.9 Billion

Q1:18 Health Care M&A Stays Strong

by | Apr 20, 2018 10:05 am | Healthcare Market Updates

Health care merger and acquisition activity in the first quarter of 2018 kept pace with the previous quarter in 2017. Compared with the fourth quarter of 2017, deal volume increased 1%, to 386 transactions. However, deal volume was down 12% compared with the same quarter the year before. Combined spending in the first quarter reached $112.9 billion, a decrease of 2% compared with the nearly $115.0 billion spent in the previous quarter, according to HealthCareMandA.com. Thanks to the announcement of a multi-billion-dollar deal in Q1:18, deal value rose 90% compared with $59.6 billion spent in Q1:17. Health Care M&A Market – Deal Volume by Sector Source: HealthCareMandA,com, April 2018... Read More »
Health Care M&A Weekly Deals, The Week Ending April 20, 2018

Health Care M&A Weekly Deals, The Week Ending April 13, 2018

by | Apr 16, 2018 8:26 am | Healthcare Market Updates

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price Summit BHC Cottonwood Tucson N/A Biotechnology Acquirer Target Price Alexion Pharmaceuticals, Inc. Wilson Therapeutics AB $855 million Promethera Biosciences Baliopharm AG N/A Novartis AG AveXis... Read More »
Health Care M&A Weekly Deals, The Week Ending April 20, 2018

Health Care M&A Weekly Deals, The Week Ending April 6, 2018

by | Apr 6, 2018 2:40 pm | Healthcare Market Updates

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Agilent Technologies Inc. Lasergen, Inc. $105 million MedImmune Exclusive license to antibody products $10 million Ferring Pharmaceuticals Rebiotix Inc. N/A UCB S.A. Element Genomics $30 million Novo... Read More »
Q1:18 Results: Healthcare Goes Retail

Q1:18 Results: Healthcare Goes Retail

by | Apr 6, 2018 11:17 am | Healthcare Market Updates

First, the easy news. Deal volume in the first quarter of 2018 was on par with the previous quarter’s total of 380 deals. Preliminary data show 378 transactions were announced in the first quarter, making for a decline of 1% that will likely be erased as more deal activity is uncovered. Compared with the first quarter in 2017, however, deal volume was down 14%, versus the 439 deals reported then. Deal value for the quarter is where the data deviates from previous norms. The first quarter in 2017 posted a very robust $59.6 billion in disclosed deal value. In the fourth quarter of the year, deal value leapt to nearly $115.0 billion, thanks largely to the $77 billion proposed acquisition of... Read More »